Kevin T.

Kevin T. currently serves as the Chief Financial Officer at Solid Biosciences since January 2023 and is an Investor at MacroXStudio, which is focused on providing real-time economic and societal metrics through a multimodal AI engine. Prior to these roles, Kevin held the position of Chief Financial Officer at Selecta Biosciences from September 2021 to December 2022, overseeing business development and investor relations. From May 2018 to September 2021, Kevin worked as Treasurer and Assistant Treasurer at Sarepta Therapeutics. Kevin has experience as a private investor and consultant from January 2017 to April 2018 and served as a Senior Portfolio Manager at CPP Investments from June 2012 to November 2016, managing diverse public market investments. Kevin holds an MBA from The University of Chicago Booth School of Business, an M.Eng in Financial Engineering from Princeton University, and a B.Com in Finance and Accounting from Smith School of Business at Queen's University.